✕
Login
Register
Back to News
Tempest Therapeutics Q4 EPS $(0.62) Beats $(3.52) Estimate
Benzinga Newsdesk
www.benzinga.com
Negative 67.6%
Neg 67.6%
Neu 0%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment